BREAKING NEWS
The Arizona Alzheimer’s Consortium honors philanthropist Michael Zuendel for extraordinary contributions to the scientific, clinical, and social fight against Alzheimer’s disease
PHOENIX, Ariz. – On Saturday, May 17 the Arizona Alzheimer’s Consortium will hold its always-anticipated public conference. This free event gathers more than 200 patients, caregivers, family members, and interested persons together with researchers, caregiving experts, and other leaders...
Read more
New ASU Health Headquarters helps advance Alzheimer’s research
Headquarters for innovations to help every family have a healthier future will be in downtown Phoenix Bioscience Core and open in time for fall 2028 semester. Click Here to Read the Full Story
Read more
ASU, TGen, and Banner researchers discover a link between a chronic gut infection and the development of Alzheimer’s disease
Arizona State University and Banner Alzheimer’s Institute researchers, along with their collaborators, have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer’s disease in a subset of people. Click...
Read moreNew Alzheimer’s prevention trial receives $74.5 million NIH grant
Two-part trial to build on landmark Colombian prevention study of people at near-certain genetic risk for early-onset Alzheimer’s disease PHOENIX (Thursday, Nov. 14) – A new Alzheimer’s prevention study has received a $74.5 million five-year grant from the National...
Read moreArizona Alzheimer’s Consortium (AAC) Biomarker Measurement Support Request for Proposals
APPLICATION RECEIPT DATE: Recommended: Pre-proposal Deadline: November 1, 2024 (Friday) Full Application Deadline: December 11, 2024 Anticipated Analysis Start Date: February 3, 2025 (Wednesday) PURPOSE: The Arizona Alzheimer’s Consortium (AAC) invites applications for biofluid biomarker analysis to advance the understanding of neurodegenerative disorders. These...
Read more
Los hispanos son 50% más propensos a contraer una enfermedad de demencia, según experto
Hay alrededor de 10 variaciones de enfermedades de demencia y la más común es el Alzheimer. Haga clic aquí para leer la historia completa. | Click Here to Read the Full Story
Read more
ASU awarded prestigious $5.8 million NIH Roybal Center
Living alone is a lesser-known risk factor for Alzheimer’s and other types of cognitive decline. With an estimated 14 million Americans aging solo — by choice or circumstance — Arizona State University has a plan to help and new...
Read more
Dr. David W. Coon awarded the M. Powell Lawton Award by the American Psychological Association’s Society of Clinical Geropsychology
Dr. David W. Coon, director of Arizona State University’s Center for Innovation in Healthy and Resilient Aging and associate dean of ASU’s Edson College of Nursing and Health Innovation, was awarded the M. Powell Lawton Award by the American...
Read more
FDA approves donanemab; Banner Alzheimer’s trial participants interviewed in N.Y. Times
FDA approves donanemab; Banner Alzheimer’s trial participants interviewed in N.Y. Times The FDA on Tuesday approved a new drug for Alzheimer’s disease, and clinical trials at both Banner Alzheimer’s Institute locations and Banner Sun Health Research Institute provided data...
Read more
Banner Health hires renowned leader for new biomarker research program
Nicholas Ashton’s program aims to discover, galvanize use of new blood tests in fight against Alzheimer’s and related diseases PHOENIX (May 15, 2024) – Emerging blood tests have begun to revolutionize the fight against Alzheimer’s disease, the most common...
Read more